Despite great efforts and advancement in the treatment of cancer, tumor recurrence and
metastasis remain significant challenges and demand novel therapy strategies. Recently …

Drug-eluting implants are one of the leading implant technologies to facilitate the healing
capacity of bones by eliminating implant-associated infections. Treatment of the infections …

Malignant glioblastoma (GBM) is prone to relapse due to the inevitable tumor cells residue
by surgery. During the tumor resection surgery in brain, addressing bleeding and superbug …

Surgery remains a primary modality of treatment for the majority of solid tumor malignancies.
While advancements in surgical technique and instrumentation have improved the quality of …

Glioblastoma (GBM) is a particularly aggressive brain cancer associated with high
recurrence and poor prognosis. The standard of care, surgical resection followed by …

Soft tissue reconstructs require materials that form three-dimensional (3-D) structures
supportive to cell proliferation and regenerative processes. Polysaccharides, due to their …

In the field of drug delivery, the most commonly used treatments have traditionally been
systemically delivered using oral or intravenous administration. The problems associated …

Even though the last decade has seen a surge in the identification of molecular targets and
targeted therapies in pediatric brain tumors, the blood brain barrier (BBB) remains a …

Effective drug delivery requires ample dosing at the target tissue while minimizing negative
side effects. Drug delivery vehicles such as polymeric nanoparticles (NPs) are often …

Also known as electrospray, electrohydrodynamic atomization has been used extensively in
the last 15 years to develop polymer-based particles for drug delivery in cell and animal …